Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
June 11, 2024

June 11, 2024
June 5, 2024
May 15, 2024
May 15, 2024
May 15, 2024
May 14, 2024
May 2, 2024
April 22, 2024
March 12, 2024
September 10, 2026
The global pharmacovigilance specialist will help drive one of Africa’s most comprehensive medicines safety initiatives. Qinecsa, the global pharmacov...
September 10, 2026
A new initiative to connect and empower early-career pathologists across Europe Sakura Finetek Europe today announced the launch of the Sakura Patholo...
September 2, 2026
Inceptua Group, a leading global provider of clinical trial supply, related services, and early access programs backed by Vesey Street Capital Partner...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225